130 related articles for article (PubMed ID: 32533280)
1. Side effects of proton beam therapy of choroidal melanoma in dependence of the dose to the optic disc and the irradiated length of the optic nerve.
Riechardt AI; Stroux A; Seibel I; Heufelder J; Zeitz O; Böhmer D; Joussen AM; Gollrad J
Graefes Arch Clin Exp Ophthalmol; 2020 Nov; 258(11):2523-2533. PubMed ID: 32533280
[TBL] [Abstract][Full Text] [Related]
2. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
[TBL] [Abstract][Full Text] [Related]
3. Proton beam therapy of parapapillary choroidal melanoma.
Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
[TBL] [Abstract][Full Text] [Related]
4. Dose-Response and Normal Tissue Complication Probabilities after Proton Therapy for Choroidal Melanoma.
Espensen CA; Kiilgaard JF; Appelt AL; Fog LS; Herault J; Maschi C; Caujolle JP; Thariat J
Ophthalmology; 2021 Jan; 128(1):152-161. PubMed ID: 32574763
[TBL] [Abstract][Full Text] [Related]
5. Proton beam therapy leads to excellent local control rates in choroidal melanoma in the intermediate fundus zone.
Schönfeld S; Cordini D; Riechardt AI; Seibel I; Willerding G; Bechrakis NE; Moser L; Joussen AM
Am J Ophthalmol; 2014 Dec; 158(6):1184-91. PubMed ID: 25128597
[TBL] [Abstract][Full Text] [Related]
6. Radiation-Induced Optic Neuropathy: Observation versus Intravitreal Treatment: Can Visual Acuity Be Maintained by Intravitreal Treatment?
Eckstein D; Riechardt AI; Heufelder J; Zeitz O; Böker A; Brockmann C; Joussen AM; Seibel I
Am J Ophthalmol; 2019 Dec; 208():289-294. PubMed ID: 31323201
[TBL] [Abstract][Full Text] [Related]
7. Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.
Riechardt AI; Klein JP; Cordini D; Heufelder J; Rehak M; Seibel I; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1325-1332. PubMed ID: 29464331
[TBL] [Abstract][Full Text] [Related]
8. Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas.
Papakostas TD; Lane AM; Morrison M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2017 Nov; 135(11):1191-1196. PubMed ID: 29049518
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC Cancer Agency.
Tran E; Ma R; Paton K; Blackmore E; Pickles T
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1425-31. PubMed ID: 22209152
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
11. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma.
Gragoudas ES; Lane AM; Regan S; Li W; Judge HE; Munzenrider JE; Seddon JM; Egan KM
Arch Ophthalmol; 2000 Jun; 118(6):773-8. PubMed ID: 10865313
[TBL] [Abstract][Full Text] [Related]
14. Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.
Riechardt AI; Karle B; Cordini D; Heufelder J; Budach V; Joussen AM; Gollrad J
Strahlenther Onkol; 2017 Nov; 193(11):943-950. PubMed ID: 28631017
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of Proton Beam Therapy for Ocular Melanoma Using a Novel 3D Treatment Planning Technique.
Hartsell WF; Kapur R; Hartsell SO; Sweeney P; Lopes C; Duggal A; Cohen J; Chang J; Polasani RS; Dunn M; Pankuch M
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):353-359. PubMed ID: 27084652
[TBL] [Abstract][Full Text] [Related]
16. Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients.
Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
Arch Ophthalmol; 2008 Nov; 126(11):1515-22. PubMed ID: 19001218
[TBL] [Abstract][Full Text] [Related]
17. Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea.
Patel AV; Lane AM; Morrison MA; Trofimov AV; Shih HA; Gragoudas ES; Kim IK
Ophthalmology; 2016 Feb; 123(2):369-377. PubMed ID: 26545316
[TBL] [Abstract][Full Text] [Related]
18. Quantification of radiation retinopathy after beam proton irradiation in centrally located choroidal melanoma.
Busch C; Löwen J; Pilger D; Seibel I; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1599-1604. PubMed ID: 29948179
[TBL] [Abstract][Full Text] [Related]
19. Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality.
Fuss M; Loredo LN; Blacharski PA; Grove RI; Slater JD
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1053-9. PubMed ID: 11240247
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
Seibel I; Riechardt AI; Heufelder J; Cordini D; Joussen AM
Am J Ophthalmol; 2017 Jun; 178():94-100. PubMed ID: 28365241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
